Cleared Traditional

Adhesive Electrodes (K212191) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K212191 · Voncare Medical Device Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2021
Decision
86d
Days
Class 2
Risk

K212191 is an FDA 510(k) clearance for the Adhesive Electrodes. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Voncare Medical Device Co., Ltd. (Boluo County, Huizhou, CN). The FDA issued a Cleared decision on October 6, 2021 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Voncare Medical Device Co., Ltd. devices

Submission Details

510(k) Number K212191 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2021
Decision Date October 06, 2021
Days to Decision 86 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
62d faster than avg
Panel avg: 148d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Irc
Charles Mack

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 97
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K212191.
Self-adhesive Electrode
K213879 · Bozhou Rongjian Medical Appliance Co., Ltd. · Jan 2022
Wrap Accessory Electrodes
K210383 · Hi-Dow International, Inc. · Nov 2021
Comby EEG Caps
K211315 · Pamel D.O.O · Nov 2021
Adhesive Electrode
K210448 · Shaoxing Yingtuo Healthcare Co., Ltd. · Aug 2021
Ceribell Instant EEG Headband
K210805 · Ceribell, Inc. · Aug 2021
Metallic Fabric Electrodes
K202636 · Guangzhou Xinbo Electronic Co., Ltd. · Aug 2021